Cardiovascular disease (CVD) represents the leading cause of death globally, claiming nearly 18 million lives annually according to the World Health Organization. Yet confusion persists about what CVD actually encompasses. While often used interchangeably with “heart disease,” cardiovascular disease is a broader umbrella term covering all conditions affecting the heart and blood vessels throughout the body — from the coronary arteries feeding your heart muscle to the carotid arteries supplying your brain to the peripheral arteries carrying blood to your legs.

This article focuses specifically on cardiovascular diseases affecting blood vessels beyond the heart itself. While coronary artery disease and other heart conditions are covered in our separate Heart Disease guide, here we examine the vascular diseases affecting circulation throughout your body: stroke and other cerebrovascular diseases, peripheral artery disease, aortic disease, and related vascular conditions. These diseases share the same underlying cause — atherosclerosis, the progressive buildup of plaque in arterial walls — and the same major risk factors including high blood pressure, diabetes, high cholesterol, smoking, and obesity.

What makes cardiovascular disease particularly devastating is that most vascular damage accumulates silently over decades. The carotid arteries supplying your brain may be 70% blocked without causing symptoms until suddenly a blood clot forms and you suffer a stroke. The arteries in your legs may narrow progressively, eventually causing pain with walking or even tissue death requiring amputation. Yet here’s the remarkable fact: approximately 80% of cardiovascular disease is preventable through risk factor management. The atherosclerotic process driving these conditions is detectable years before complications occur through comprehensive metabolic testing revealing insulin resistance, dyslipidemia, inflammation, and other modifiable factors.

Understanding cardiovascular disease—how atherosclerosis damages vessels throughout your body, which warning signs require emergency response, which risk factors you can modify, and how to detect vascular disease before catastrophic events occur — provides the knowledge foundation for preserving your vascular health and avoiding what remains, despite being largely preventable, the leading cause of death and disability worldwide.

Quick Summary:

• Cardiovascular disease (CVD) encompasses all conditions affecting the heart and blood vessels throughout the body
• CVD kills 17.9 million people annually making it the #1 cause of death globally
• This article covers vascular diseases affecting vessels beyond the heart: stroke, peripheral artery disease, and related conditions
• Atherosclerosis is the underlying process causing most CVD—plaque buildup in arterial walls developing over decades
• Stroke is the #5 cause of death and leading cause of serious disability, affecting 795,000 Americans annually
• 80% of strokes are preventable through risk factor management and lifestyle interventions
• Peripheral artery disease (PAD) affects 8-12 million Americans causing leg pain, poor wound healing, and amputation risk
• Major modifiable risk factors: High blood pressure (most important for stroke), diabetes, high cholesterol, smoking, obesity, physical inactivity
• Metabolic testing reveals hidden vascular risk years before symptoms: blood pressure, lipid panel, glucose/insulin, kidney function, inflammatory markers
• FAST acronym recognizes stroke: Face drooping, Arm weakness, Speech difficulty, Time to call 911 immediately
• Evidence-based prevention works: Blood pressure control reduces stroke risk 30-40%, statins reduce vascular events 25-35%, lifestyle changes prevent 80% of CVD
• Early detection is crucial because vascular damage accumulates silently—comprehensive metabolic assessment identifies risk before complications occur

---

What Is Cardiovascular Disease?

Cardiovascular disease is an umbrella term encompassing all diseases of the heart and blood vessels. The cardiovascular system consists of the heart (the pump), arteries (vessels carrying oxygen-rich blood from the heart to tissues), and veins (vessels returning oxygen-depleted blood to the heart). Disease can affect any component of this system.

While “cardiovascular disease” and “heart disease” are often used interchangeably, cardiovascular disease technically includes a broader range of conditions. Heart disease refers specifically to conditions affecting the heart itself—coronary artery disease, heart attack, heart failure, arrhythmias, and valve disease. These heart-specific conditions are covered in detail in our Heart Disease guide.

This article focuses on cardiovascular diseases primarily affecting blood vessels throughout the body beyond the heart itself. These vascular diseases share atherosclerosis as their fundamental underlying process and the same major risk factors, but they affect different vascular territories causing distinct clinical manifestations.

Major Types of Cardiovascular Disease Covered Here

Cerebrovascular Disease (Stroke and TIA):

Diseases affecting blood vessels supplying the brain. Ischemic stroke occurs when a blood clot blocks blood flow to brain tissue, causing brain cell death. Hemorrhagic stroke results from bleeding into or around the brain. Transient ischemic attack (TIA) is a temporary interruption of blood flow causing stroke-like symptoms that resolve, serving as a critical warning sign of stroke risk.

Peripheral Artery Disease (PAD):

Narrowing of arteries carrying blood to the limbs, most commonly the legs. PAD causes claudication (leg pain with walking), poor wound healing, and in severe cases, critical limb ischemia requiring amputation. PAD also serves as a marker for advanced atherosclerosis throughout the body, indicating high heart attack and stroke risk.

Carotid Artery Disease:

Narrowing of the carotid arteries in the neck supplying blood to the brain. Carotid stenosis often causes no symptoms until severe but dramatically increases stroke risk. Carotid disease exemplifies how atherosclerosis progresses silently over decades before causing catastrophic events.

Aortic Disease:

Diseases affecting the aorta, the body’s largest artery. Aortic aneurysm (abnormal bulging) can rupture with high mortality. Aortic dissection (tearing of the aortic wall layers) is a life-threatening emergency. Atherosclerosis and hypertension are major contributors.

Renal Artery Disease:

Narrowing of arteries supplying the kidneys, causing renovascular hypertension (high blood pressure from reduced kidney blood flow) and progressive kidney damage. Often asymptomatic until advanced.

Mesenteric Artery Disease:

Narrowing of arteries supplying the intestines, causing abdominal pain after eating and weight loss. Acute mesenteric ischemia (sudden blockage) is a surgical emergency.

While coronary artery disease (affecting heart arteries) is the most common and deadly cardiovascular disease, it’s covered separately in our Heart Disease guide. This article focuses on the vascular diseases listed above, all stemming from the same atherosclerotic process affecting different arterial territories.

---

Atherosclerosis: The Underlying Disease Process

Atherosclerosis is the fundamental pathological process underlying most cardiovascular disease. Understanding atherosclerosis—how it develops, why it affects certain arteries, and how it progresses from benign to dangerous—is essential for understanding cardiovascular disease prevention and treatment.

What Is Atherosclerosis?

Atherosclerosis is the progressive buildup of plaque within arterial walls. Plaque consists of cholesterol (particularly LDL cholesterol), inflammatory cells (mainly macrophages), smooth muscle cells, calcium, and cellular debris. As plaque accumulates, it narrows the arterial lumen (the opening through which blood flows), reducing blood flow to downstream tissues. More dangerously, plaque can rupture, triggering blood clot formation that suddenly and completely blocks blood flow, causing stroke, heart attack, or critical limb ischemia.

Importantly, atherosclerosis is not simply “clogged pipes” from cholesterol deposits. It’s an active inflammatory disease process involving complex interactions between lipoproteins, endothelial cells lining arterial walls, immune cells, and smooth muscle cells. This understanding explains why anti-inflammatory interventions and immune-modulating therapies show promise for cardiovascular disease prevention.

The Five Stages of Atherosclerosis Development

Stage 1: Endothelial Dysfunction

The process begins with injury to the endothelium, the single-cell-thick lining of arterial walls. Risk factors including high blood pressure, diabetes, smoking, high LDL cholesterol, and inflammation damage endothelial cells, impairing their normal protective functions. Healthy endothelium produces nitric oxide promoting vessel dilation, prevents blood clots, and resists inflammatory cell adhesion. Dysfunctional endothelium loses these protective properties, becoming permeable to cholesterol and attractive to inflammatory cells.

Critically, endothelial dysfunction is reversible at this stage through risk factor management—one reason early intervention is so valuable.

Stage 2: LDL Accumulation and Oxidation

Once endothelium is damaged, LDL cholesterol particles penetrate the arterial wall and become trapped in the subendothelial space (between endothelial cells and deeper arterial layers). These trapped LDL particles undergo oxidation, becoming oxidized LDL (oxLDL). Oxidized LDL is highly inflammatory and toxic to surrounding cells. High LDL cholesterol levels increase the rate of LDL accumulation, while antioxidant deficiency and oxidative stress accelerate oxidation. This explains why LDL cholesterol is the primary therapeutic target—reducing LDL slows plaque progression at this crucial early stage.

Stage 3: Inflammatory Response and Fatty Streak Formation

Oxidized LDL triggers inflammatory signaling, causing endothelial cells to express adhesion molecules attracting immune cells. Monocytes (a type of white blood cell) adhere to arterial walls, penetrate into the subendothelial space, and transform into macrophages. These macrophages engulf oxidized LDL, becoming foam cells (macrophages engorged with cholesterol appearing “foamy” under microscopy). Accumulation of foam cells forms fatty streaks—the earliest visible atherosclerotic lesions.

Fatty streaks appear in arteries beginning in childhood or adolescence but remain clinically silent for decades. They’re potentially reversible at this stage through aggressive risk factor modification.

Stage 4: Plaque Growth and Arterial Remodeling

As foam cells die, they release their cholesterol contents into the arterial wall, forming a necrotic core (dead cellular debris rich in cholesterol). Smooth muscle cells migrate from deeper arterial layers, proliferate, and produce collagen forming a fibrous cap covering the lipid core. The growing plaque initially expands outward (positive remodeling), preserving the arterial lumen. This explains why coronary arteries can have substantial atherosclerotic burden before causing symptoms—the artery compensates by expanding.

Eventually, positive remodeling capacity is exhausted and plaque begins narrowing the lumen. In coronary arteries, this causes angina (chest pain with exertion). In carotid arteries, this creates stroke risk. In peripheral arteries, this causes claudication (leg pain with walking).

Stage 5: Plaque Rupture and Thrombosis

The most dangerous development is plaque rupture. Some plaques remain stable for years, gradually narrowing arteries but rarely causing acute events. Other plaques are vulnerable (unstable)—they have thin fibrous caps, large lipid cores, and intense inflammation. When vulnerable plaque ruptures, the thrombogenic lipid core is exposed to blood, triggering rapid blood clot (thrombus) formation.

This thrombus can suddenly and completely occlude the artery, cutting off blood flow to downstream tissue. In coronary arteries, this causes heart attack. In carotid or cerebral arteries, this causes stroke. In peripheral arteries, this causes acute limb ischemia. Plaque rupture explains why cardiovascular events are often sudden and unpredictable—a person may have stable disease for years, then experience a catastrophic event when an unstable plaque ruptures.

Importantly, the degree of stenosis (arterial narrowing) doesn’t predict rupture risk. Mildly narrowed arteries with vulnerable plaque cause more acute events than severely narrowed arteries with stable plaque. This is why preventive strategies focus on plaque stabilization (through lipid lowering, blood pressure control, and anti-inflammatory interventions) rather than just addressing symptoms from severely narrowed arteries.

Why Atherosclerosis Affects Different Arteries

Atherosclerosis doesn’t affect all arteries equally. It preferentially develops at arterial branch points and areas of turbulent blood flow where endothelial cells experience mechanical stress. Certain arterial beds are particularly vulnerable:

• Carotid arteries: Especially the carotid bifurcation (where the common carotid splits into internal and external carotid) due to turbulent flow
• Coronary arteries: Particularly the left anterior descending artery and its branches
• Peripheral arteries: Especially the superficial femoral artery in the thigh and below-knee arteries
• Aorta: Particularly the abdominal aorta below the renal arteries

Individual variation in atherosclerosis distribution partly explains why some people develop stroke without significant coronary disease, while others have severe coronary disease with little cerebrovascular or peripheral disease. However, atherosclerosis is generally a systemic process—people with significant disease in one vascular bed often have disease in others, even if asymptomatic. This is why someone diagnosed with peripheral artery disease should undergo cardiac evaluation, and why stroke survivors have high heart attack risk.

The Role of Inflammation

Modern understanding recognizes atherosclerosis as fundamentally an inflammatory disease. At every stage, inflammation drives progression. Inflammatory cytokines promote endothelial dysfunction. Inflammatory cells accumulate in plaques. Inflammation makes plaques vulnerable to rupture.

This insight has therapeutic implications. Inflammatory markers like high-sensitivity C-reactive protein (hsCRP) predict cardiovascular events independently of cholesterol levels. Anti-inflammatory medications show cardiovascular benefit. Lifestyle interventions reducing inflammation—particularly Mediterranean diet, exercise, weight loss, and smoking cessation—protect against atherosclerosis progression.

The inflammatory nature of atherosclerosis also explains why conditions causing chronic inflammation (rheumatoid arthritis, lupus, chronic kidney disease) accelerate cardiovascular disease. Metabolic syndrome and insulin resistance, both inflammatory states, similarly accelerate atherosclerosis. This mechanistic understanding emphasizes that optimal cardiovascular disease prevention requires addressing inflammation, not just cholesterol.

---

Stroke and Cerebrovascular Disease

Stroke is the leading cause of serious long-term disability and the fifth leading cause of death in the United States, affecting approximately 795,000 Americans annually. Yet stroke is among the most preventable major diseases—approximately 80% of strokes are preventable through risk factor management and lifestyle modifications. Understanding stroke—types, warning signs, risk factors, and prevention strategies—is essential for everyone, as recognizing and responding to stroke symptoms can mean the difference between minimal disability and devastating loss of function or death.

What Is a Stroke?

A stroke occurs when blood supply to part of the brain is interrupted, depriving brain cells of oxygen and nutrients. Brain tissue begins dying within minutes. The resulting symptoms depend on which brain region is affected and how much tissue is damaged—stroke can cause paralysis, speech difficulties, vision loss, cognitive impairment, or death.

Time is critical in stroke treatment. The window for most effective intervention is measured in hours. This is why immediate recognition of stroke symptoms and emergency response are crucial—”Time is brain,” meaning every minute of delayed treatment allows more brain damage.

Types of Stroke

Ischemic Stroke (87% of strokes):

Caused by blockage of a blood vessel supplying the brain. The blockage is typically a blood clot, either:

• Thrombotic stroke: A clot forms in an artery already narrowed by atherosclerosis, usually the carotid arteries or cerebral arteries
• Embolic stroke: A clot forms elsewhere (often the heart in people with atrial fibrillation) and travels to the brain, lodging in a cerebral artery

Large vessel occlusion (blockage of major cerebral arteries) causes more severe strokes than small vessel occlusion. Lacunar strokes result from occlusion of small penetrating arteries deep in the brain, often related to chronic hypertension.

Hemorrhagic Stroke (13% of strokes):

Caused by bleeding into or around the brain:

• Intracerebral hemorrhage: Bleeding directly into brain tissue, usually from a ruptured small artery damaged by chronic hypertension
• Subarachnoid hemorrhage: Bleeding into the space surrounding the brain, usually from a ruptured aneurysm (abnormal bulging of an artery)

Hemorrhagic strokes are less common but more often fatal than ischemic strokes. Uncontrolled hypertension is the primary modifiable risk factor.

Transient Ischemic Attack (TIA):

A “mini-stroke” or “warning stroke” causing temporary neurological symptoms that resolve within 24 hours (usually within 1 hour). TIA results from temporary blood flow interruption, often from a small clot that dissolves or passes through. While symptoms resolve, TIA is a medical emergency signaling high stroke risk—10-15% of TIA patients have a major stroke within 3 months, with highest risk in the first 48 hours. Anyone experiencing TIA symptoms needs immediate medical evaluation and stroke prevention treatment.

Recognizing Stroke: The FAST Test

Rapid stroke recognition and immediate emergency response are critical. The FAST acronym helps everyone remember stroke warning signs:

F – Face Drooping: Does one side of the face droop or is it numb? Ask the person to smile. Is the smile uneven?

A – Arm Weakness: Is one arm weak or numb? Ask the person to raise both arms. Does one arm drift downward?

S – Speech Difficulty: Is speech slurred? Is the person unable to speak or hard to understand? Ask the person to repeat a simple sentence like “The sky is blue.” Can they repeat it correctly?

T – Time to Call 911: If someone shows any of these symptoms, even if symptoms go away, call 911 immediately. Note the time symptoms first appeared—this information is critical for treatment decisions.

Additional stroke warning signs include:

• Sudden numbness or weakness of face, arm, or leg, especially on one side
• Sudden confusion or trouble understanding speech
• Sudden trouble seeing in one or both eyes
• Sudden trouble walking, dizziness, loss of balance or coordination
• Sudden severe headache with no known cause

Women may experience additional symptoms including sudden hiccups, nausea, general weakness, chest pain, shortness of breath, or palpitations. Anyone experiencing these symptoms should seek immediate medical attention.

Stroke Risk Factors

Major Modifiable Risk Factors:

High Blood Pressure (Most Important):

Hypertension is the single most important modifiable stroke risk factor, increasing stroke risk 3-4 fold. High blood pressure damages arterial walls, accelerates atherosclerosis, and increases hemorrhagic stroke risk by stressing small vessels prone to rupture. Blood pressure control reduces stroke risk by 30-40%, making it the most effective stroke prevention intervention.

Target blood pressure for stroke prevention: <130/80 mmHg for most people, though individual targets vary based on age and comorbidities.

Diabetes:

Diabetes approximately doubles stroke risk through multiple mechanisms: accelerating atherosclerosis, promoting blood clot formation, and causing microvascular damage. Both type 1 and type 2 diabetes increase risk, with risk proportional to glycemic control quality. Intensive diabetes management reduces stroke risk, though benefits are more modest than for blood pressure control.

High Cholesterol and Dyslipidemia:

Elevated LDL cholesterol accelerates atherosclerosis in carotid and cerebral arteries. While the relationship between cholesterol and stroke is less direct than for heart attack, statin therapy reduces stroke risk by approximately 25% through LDL lowering and plaque stabilization.

Atrial Fibrillation:

This heart rhythm disorder increases stroke risk 5-fold by allowing blood clots to form in the heart and embolize to the brain. About 15% of strokes occur in people with atrial fibrillation. Anticoagulation (blood thinners) dramatically reduces stroke risk in atrial fibrillation.

Smoking:

Smoking approximately doubles stroke risk through multiple mechanisms: damaging endothelium, promoting blood clot formation, raising blood pressure, and accelerating atherosclerosis. Smoking cessation reduces stroke risk by 50% within 1-2 years, eventually approaching that of never-smokers.

Obesity:

Obesity increases stroke risk 1.5-2 fold, primarily through promoting other risk factors (hypertension, diabetes, dyslipidemia, atrial fibrillation). Abdominal obesity shows particularly strong associations with stroke risk.

Physical Inactivity:

Sedentary lifestyle increases stroke risk 1.5-2 fold. Regular physical activity reduces risk through multiple mechanisms: lowering blood pressure, improving cholesterol, aiding weight management, improving glucose metabolism, and reducing inflammation.

Diet:

Diets high in sodium, saturated fat, and processed foods increase stroke risk, while Mediterranean-style diets rich in vegetables, fruits, fish, olive oil, and whole grains reduce risk by 20-30%.

Excessive Alcohol:

Heavy drinking increases stroke risk, particularly hemorrhagic stroke. Moderate alcohol consumption (1 drink daily for women, 2 for men) may slightly reduce ischemic stroke risk but increases hemorrhagic stroke risk.

Non-Modifiable Risk Factors:

• Age: Stroke risk doubles each decade after age 55
• Sex: Men have higher stroke incidence until age 75, then women’s rates exceed men’s
• Race/Ethnicity: African Americans have nearly twice the stroke risk of whites, with earlier onset and greater severity
• Family History: First-degree relatives of stroke survivors have increased risk
• Previous Stroke or TIA: Dramatically increases future stroke risk

Acute Stroke Treatment

Ischemic Stroke:

tPA (Tissue Plasminogen Activator):

A clot-dissolving drug administered intravenously, effective only if given within 4.5 hours of symptom onset (ideally within 3 hours). tPA can dissolve the clot, restore blood flow, and dramatically improve outcomes if given quickly. This narrow time window is why immediate emergency response to stroke symptoms is critical.

Mechanical Thrombectomy:

For large vessel occlusions, interventional neuroradiologists can insert a catheter through a groin artery, navigate to the blocked brain artery, and physically remove the clot. This procedure is effective up to 24 hours after symptom onset in selected patients. Availability of thrombectomy at comprehensive stroke centers has revolutionized stroke care over the past decade.

Supportive Care:

Blood pressure management, prevention of complications, rehabilitation planning.

Hemorrhagic Stroke:

Treatment focuses on stopping bleeding, reducing pressure on brain tissue, preventing complications, and in some cases, surgical intervention to remove blood or repair aneurysms.

Stroke Prevention

Primary Prevention (Before First Stroke):

Blood Pressure Control:

The most effective stroke prevention strategy. Target <130/80 mmHg through lifestyle modifications and medications if needed.

Cholesterol Management:

Statin therapy for people with elevated cardiovascular risk. Target LDL <100 mg/dL, <70 mg/dL for very high risk individuals.

Diabetes Management:

Glycemic control (target HbA1c <7% for most people), blood pressure control, and cardiovascular risk factor management.

Antiplatelet Therapy:

Aspirin or other antiplatelet agents for people at high cardiovascular risk without contraindications.

Lifestyle Interventions:

• Mediterranean-style diet emphasizing vegetables, fruits, whole grains, fish, olive oil
• Regular physical activity (150 minutes moderate-intensity weekly)
• Weight management (5-10% weight loss if overweight)
• Smoking cessation
• Moderate alcohol consumption or abstinence
• Sleep quality (7-9 hours nightly)

Secondary Prevention (After Stroke or TIA):

Prevention strategies become even more aggressive after a stroke or TIA:

• Intensive blood pressure control
• High-intensity statin therapy
• Antiplatelet therapy (aspirin, clopidogrel, or combination)
• Anticoagulation for atrial fibrillation
• Carotid revascularization (endarterectomy or stenting) for severe carotid stenosis
• Aggressive risk factor modification
• Cardiac evaluation to identify atrial fibrillation or other cardiac sources of emboli

Recovery and Rehabilitation

Stroke recovery varies widely depending on stroke severity, location, and promptness of treatment. Many stroke survivors experience some recovery, particularly in the first three months, though some deficits may be permanent.

Comprehensive stroke rehabilitation includes:

• Physical therapy for mobility and strength
• Occupational therapy for daily living skills
• Speech therapy for language and swallowing difficulties
• Cognitive therapy for memory and thinking problems
• Psychological support for depression and emotional adjustment

Recovery is often a long-term process requiring patience, intensive therapy, and strong support systems.

---

Peripheral Artery Disease (PAD)

Peripheral artery disease affects 8-12 million Americans, yet remains significantly underdiagnosed and undertreated despite its serious implications for both limb and cardiovascular health. PAD results from atherosclerosis narrowing arteries that carry blood to the limbs, most commonly the legs. Beyond causing debilitating leg pain and potential amputation, PAD serves as a marker for advanced atherosclerosis throughout the body—people with PAD have dramatically elevated heart attack and stroke risk.

What Is Peripheral Artery Disease?

PAD occurs when atherosclerotic plaque narrows peripheral arteries, reducing blood flow to limbs. The legs are most commonly affected, though PAD can affect arteries supplying the arms, stomach, intestines, and kidneys. Reduced blood flow to leg muscles causes claudication (muscle pain with exercise), while severely compromised blood flow can cause tissue damage, non-healing wounds, gangrene, and eventual amputation.

PAD severity ranges from asymptomatic disease (many people with PAD have no symptoms) to claudication (pain with walking) to critical limb ischemia (rest pain, non-healing wounds, tissue loss).

Symptoms of Peripheral Artery Disease

Intermittent Claudication:

The classic PAD symptom, claudication is cramping muscle pain in the legs triggered by walking and relieved by rest. The pain occurs because narrowed arteries cannot supply adequate blood flow to meet exercising muscles’ oxygen demands. Pain location reflects which arteries are diseased:

• Buttock and hip pain: Aortoiliac disease (blockages in aorta or iliac arteries)
• Thigh pain: Common femoral or superficial femoral artery disease
• Calf pain: Superficial femoral or popliteal artery disease (most common)
• Foot pain: Tibial or peroneal artery disease

Claudication characteristically occurs at a predictable walking distance, causes the person to stop walking, resolves within minutes of rest, and recurs with renewed walking. This reproducible pattern distinguishes claudication from other causes of leg pain.

Importantly, claudication is more than an inconvenience—it severely limits physical activity, impairs quality of life, increases fall risk, and often leads to progressive deconditioning worsening overall health.

Asymptomatic PAD:

Many people with PAD experience no symptoms, particularly if they’re sedentary or have adapted by limiting physical activity. Asymptomatic PAD still indicates advanced atherosclerosis and elevated cardiovascular risk.

Critical Limb Ischemia:

The most severe PAD manifestation, critical limb ischemia occurs when arterial blockages are so severe that blood flow is insufficient even at rest. Symptoms include:

• Rest pain: Severe pain in feet or toes even when not walking, often worse at night and when legs are elevated
• Non-healing wounds or ulcers on feet or toes
• Gangrene: Tissue death appearing as black, mummified tissue

Critical limb ischemia is a medical emergency requiring immediate revascularization (restoring blood flow) to save the limb. Without treatment, amputation is usually necessary.

Other PAD Symptoms:

• Leg fatigue or heaviness with walking
• Coldness in the lower leg or foot
• Shiny skin on legs
• Thickened, slow-growing toenails
• Absent or weak pulses in legs or feet
• Erectile dysfunction in men (often from pelvic arterial disease)

[H3] Risk Factors for Peripheral Artery Disease

PAD shares the same risk factors as other forms of atherosclerotic cardiovascular disease, though some show particularly strong associations:

Smoking (Strongest Association):

Smoking increases PAD risk more dramatically than heart disease risk. Current smokers have 4-5 times higher PAD risk than never-smokers, and smoking is present in 80-90% of PAD cases. Smoking also accelerates PAD progression and worsens outcomes. Smoking cessation is the single most important intervention for PAD.

Diabetes:

Diabetes increases PAD risk 2-4 fold. Diabetic PAD tends to affect more distal arteries (below the knee), heal more poorly, and result in higher amputation rates.

Other Major Risk Factors:

• Hypertension
• High cholesterol
• Age >65 years (though smokers and diabetics develop PAD at younger ages)
• African American race
• Chronic kidney disease
• Previous heart attack or stroke

[H3] Diagnosis of Peripheral Artery Disease

Ankle-Brachial Index (ABI):

The primary screening test for PAD, ABI compares blood pressure in the ankles to blood pressure in the arms. Normally, ankle pressure equals or slightly exceeds arm pressure (ABI 1.0-1.4). In PAD, ankle pressure is lower due to arterial blockages (ABI <0.90 indicates PAD). ABI is simple, non-invasive, takes about 15 minutes, and accurately identifies PAD.

ABI interpretation:

• 1.0-1.4: Normal
• 0.90-0.99: Borderline
• 0.70-0.89: Mild PAD
• 0.40-0.69: Moderate PAD
• <0.40: Severe PAD

Physical Examination:

Examination findings suggesting PAD include absent or weak pulses in legs or feet, cool skin temperature, poor hair growth on legs, shiny skin, thickened toenails, and muscle atrophy.

Imaging Studies:

Duplex Ultrasound: Uses sound waves to visualize arteries and measure blood flow CT Angiography or MR Angiography: Provides detailed arterial imaging Conventional Angiography: Catheter-based imaging providing the highest resolution images, usually performed when revascularization is planned

Treatment and Management of PAD

Medical Management:

Antiplatelet Therapy:

Aspirin or clopidogrel reduces heart attack, stroke, and cardiovascular death risk in PAD patients by 25%. All PAD patients should receive antiplatelet therapy unless contraindicated.

Statin Therapy:

High-intensity statins reduce cardiovascular events and may modestly improve claudication. All PAD patients should receive statin therapy targeting LDL <70 mg/dL.

Blood Pressure Control:

Target <130/80 mmHg (though <120/80 mmHg may provide additional benefit). ACE inhibitors or ARBs are preferred blood pressure medications due to additional vascular protective effects.

Diabetes Management:

Glycemic control (target HbA1c <7% for most patients) plus aggressive cardiovascular risk factor management.

Cilostazol:

A medication specifically approved for claudication, cilostazol improves walking distance by 50-100% in responders through vasodilation and antiplatelet effects. Not suitable for patients with heart failure.

Lifestyle Interventions:

Smoking Cessation:

The most important intervention. Smoking cessation improves symptoms, slows progression, and dramatically improves overall outcomes. All smoking cessation methods (counseling, nicotine replacement, prescription medications) should be offered.

Supervised Exercise Therapy:

The most effective treatment for claudication, supervised exercise involves structured walking programs 3 times weekly for 12 weeks or longer. Patients walk until experiencing moderate pain, rest until pain resolves, and repeat. This training improves collateral circulation, enhances muscle oxygen extraction, and improves walking distance by 150-200%. Exercise benefits exceed those from revascularization procedures for claudication.

Diet:

Mediterranean diet or other heart-healthy dietary patterns reduce cardiovascular events. Weight loss of 5-10% improves symptoms and reduces cardiovascular risk.

Foot Care:

Daily foot inspection, proper footwear, immediate treatment of minor injuries, and regular podiatric care prevent wounds and ulcers, particularly crucial for people with diabetes and PAD.

Revascularization Procedures:

For patients with lifestyle-limiting claudication despite medical therapy or critical limb ischemia:

Endovascular Procedures:

Angioplasty (balloon inflation to compress plaque), often with stent placement (metal scaffold holding artery open). Performed through catheters inserted via groin arteries, endovascular procedures are less invasive than surgery.

Surgical Bypass:

Creating a detour around blocked artery using a vein graft or synthetic graft. Reserved for more extensive disease or when endovascular options are unsuitable.

Both approaches have similar long-term outcomes for claudication treatment, though endovascular procedures have lower procedural risks and quicker recovery while surgical bypass may have better long-term durability for extensive disease.

Preventing PAD and Reducing Cardiovascular Risk

PAD indicates advanced systemic atherosclerosis—people with PAD have 2-3 times higher risk of heart attack and stroke compared to those without PAD. Comprehensive cardiovascular risk management is crucial:

• Aggressive lipid management (statins, ezetimibe, PCSK9 inhibitors when needed)
• Stringent blood pressure control
• Antiplatelet therapy
• Diabetes management
• Smoking cessation
• Regular exercise
• Heart-healthy diet
• Weight management

These interventions reduce cardiovascular events (heart attack, stroke, cardiovascular death) by 50% or more in PAD patients, making them as important as PAD-specific treatments.

---

Risk Factors for Cardiovascular Disease

The same risk factors that cause coronary artery disease also cause stroke, peripheral artery disease, and other vascular conditions. These factors damage endothelium and accelerate atherosclerosis throughout the arterial tree.

Major Modifiable Risk Factors

High Blood Pressure (Hypertension):

Hypertension is the most important modifiable risk factor for stroke and a major contributor to all cardiovascular disease. High blood pressure damages arterial walls through mechanical stress, accelerates atherosclerosis, and increases hemorrhagic stroke risk. Blood pressure control reduces stroke risk 30-40% and overall cardiovascular events by 20-25%. Target <130/80 mmHg for most people.

Diabetes Mellitus:

Both type 1 and type 2 diabetes dramatically accelerate atherosclerosis and increase all cardiovascular disease types. Diabetes approximately doubles cardiovascular risk through multiple mechanisms: damaging endothelium, promoting inflammation, causing dyslipidemia, and increasing blood clot formation. Glycemic control, blood pressure management, lipid management, and antiplatelet therapy reduce cardiovascular complications.

High Cholesterol (Dyslipidemia):

Elevated LDL cholesterol is the primary driver of atherosclerosis. Statin therapy reducing LDL by 40 mg/dL decreases cardiovascular events by approximately 25%. Target LDL <100 mg/dL for moderate risk, <70 mg/dL for high risk, <55 mg/dL for very high risk individuals.

Smoking:

Smoking damages endothelium, promotes inflammation, increases blood clotting, and accelerates atherosclerosis in all vascular beds. Smoking cessation reduces cardiovascular risk by 50% within 1-2 years.

Obesity:

Particularly abdominal obesity, which promotes insulin resistance, dyslipidemia, hypertension, and inflammation. Weight loss of 5-10% improves all cardiovascular risk factors.

Physical Inactivity:

Sedentary lifestyle increases cardiovascular risk 1.5-2 fold. Regular physical activity (150 minutes moderate-intensity weekly) reduces cardiovascular events by 30-40%.

Unhealthy Diet:

Diets high in sodium, saturated fat, and processed foods increase cardiovascular risk. Mediterranean diet reduces cardiovascular events by 30%.

Non-Modifiable Risk Factors

Age:

Cardiovascular disease risk increases progressively with age due to cumulative atherosclerosis exposure and age-related arterial changes.

Sex:

Men develop cardiovascular disease earlier than women, though women’s risk increases after menopause and eventually exceeds men’s in older age groups.

Family History:

First-degree relatives of people with premature cardiovascular disease (men <55 years, women <65 years) have increased risk.

Race/Ethnicity:

African Americans have higher hypertension rates and stroke risk. South Asians have higher diabetes and premature coronary disease rates.

---

Diagnosis and Testing for Cardiovascular Disease

Early detection of cardiovascular disease through appropriate diagnostic testing allows intervention before catastrophic events occur. Different vascular conditions require different diagnostic approaches, ranging from simple office-based tests to advanced imaging techniques. Understanding which tests are appropriate for different situations enables effective disease detection and monitoring.

Diagnosing Stroke and Cerebrovascular Disease

Emergency Imaging (Acute Stroke):

When someone presents with stroke symptoms, immediate brain imaging is critical to distinguish ischemic from hemorrhagic stroke and determine treatment eligibility.

CT Scan (Computed Tomography):

Non-contrast CT is the first imaging test performed in suspected stroke, completed within minutes of emergency department arrival. CT rapidly identifies hemorrhagic stroke (bleeding appears bright white) and rules out other conditions mimicking stroke (brain tumors, subdural hematoma). However, early ischemic stroke may not be visible on CT for several hours, appearing as subtle loss of gray-white matter distinction or hyperdense artery sign (visible clot in a major vessel).

CT’s primary value in acute stroke is speed—it can be performed in 5-10 minutes, allowing rapid tPA treatment decisions. CT is sufficient for most acute stroke treatment decisions despite lower sensitivity than MRI for early ischemic changes.

CT Angiography (CTA):

Often performed immediately after non-contrast CT, CTA uses intravenous contrast to visualize arteries supplying the brain. CTA identifies large vessel occlusions (blockages of major cerebral arteries) determining mechanical thrombectomy eligibility. CTA also detects carotid artery stenosis and intracranial aneurysms. The entire CT plus CTA protocol takes 10-15 minutes, providing comprehensive stroke evaluation rapidly enough to preserve treatment options.

MRI (Magnetic Resonance Imaging):

MRI is more sensitive than CT for detecting early ischemic stroke, showing acute infarction within minutes as restricted diffusion on diffusion-weighted imaging (DWI). MRI provides superior visualization of posterior circulation strokes (brainstem and cerebellum), small lacunar strokes, and stroke mimics. However, MRI takes 30-45 minutes, limiting its use in acute stroke when treatment time windows are measured in hours.

MRI is preferred for:

• Subacute stroke evaluation (days after symptom onset)
• TIA workup where CT may be normal
• Posterior circulation stroke suspicion
• Detailed stroke characterization for research or specific clinical questions

MR Angiography (MRA):

MRA visualizes cerebral and cervical arteries without radiation or iodinated contrast (though gadolinium contrast may be used for enhanced detail). MRA is valuable for detecting intracranial stenosis, aneurysms, and vascular malformations. However, MRA tends to overestimate stenosis severity compared to conventional angiography.

Carotid Doppler Ultrasound:

Non-invasive test using sound waves to visualize carotid arteries in the neck and measure blood flow velocity. Increased velocity indicates stenosis (narrowing). Carotid ultrasound is the screening test of choice for carotid artery disease, identifying patients requiring more detailed imaging or intervention. It’s performed routinely after ischemic stroke or TIA to detect carotid stenosis as the stroke mechanism.

Advantages: No radiation, no contrast, relatively inexpensive, can be performed at bedside Limitations: Operator-dependent, limited by anatomy (obesity, short neck), cannot visualize intracranial vessels

Conventional Angiography (Catheter Angiography):

The gold standard for vascular imaging, conventional angiography involves inserting a catheter through a groin artery, navigating to cerebral vessels, and injecting contrast while taking X-ray images. This provides the highest resolution arterial images, accurately measures stenosis severity, and allows therapeutic intervention (angioplasty, stenting, aneurysm coiling) during the same procedure.

Conventional angiography is typically reserved for:

• Mechanical thrombectomy during acute stroke treatment
• Pre-operative evaluation of severe carotid stenosis when ultrasound and CTA/MRA show discordant results
• Diagnosis and treatment of intracranial aneurysms
• Complex vascular malformations

Risks include stroke (0.5-1%), arterial injury, bleeding, and contrast reactions, making it inappropriate for routine screening.

Echocardiography (Heart Ultrasound):

Transthoracic echocardiography (TTE) evaluates cardiac structure and function, identifying potential cardiac sources of emboli: left ventricular thrombus, left atrial thrombus, valvular vegetations (endocarditis), patent foramen ovale (PFO), atrial septal defect, or severe left ventricular dysfunction.

Transesophageal echocardiography (TEE) provides superior visualization of left atrium, left atrial appendage (where clots form in atrial fibrillation), and cardiac valves. TEE is more sensitive than TTE for detecting cardiac sources of emboli but requires sedation and esophageal probe insertion.

Electrocardiogram (ECG) and Cardiac Monitoring:

ECG identifies atrial fibrillation, the most common cardiac cause of embolic stroke. However, atrial fibrillation may be paroxysmal (intermittent), requiring extended cardiac monitoring. Options include:

• 24-48 hour Holter monitor
• 30-day event recorder
• Implantable loop recorder (monitors for years, highest sensitivity for detecting paroxysmal atrial fibrillation)

Extended cardiac monitoring is recommended after cryptogenic stroke (stroke with no identified cause after standard evaluation) as approximately 25% of these patients have paroxysmal atrial fibrillation detected with prolonged monitoring.

[H3] Diagnosing Peripheral Artery Disease

Ankle-Brachial Index (ABI):

The primary screening test for PAD, ABI compares blood pressure in the ankles to blood pressure in the arms using a standard blood pressure cuff and Doppler ultrasound probe. The test takes 10-15 minutes and accurately identifies PAD with 90% sensitivity.

Procedure: Blood pressure is measured in both arms (using the higher value) and both ankles (posterior tibial and dorsalis pedis arteries). ABI is calculated for each leg by dividing ankle pressure by arm pressure.

ABI interpretation:

• 1.0-1.4: Normal
• 0.90-0.99: Borderline (consider exercise ABI)
• 0.70-0.89: Mild PAD
• 0.40-0.69: Moderate PAD
• <0.40: Severe PAD
• 1.40: Non-compressible vessels (calcified arteries, common in diabetes—unreliable result)

Exercise ABI:

Some patients have normal resting ABI but develop symptoms with exercise due to flow-limiting stenosis that becomes apparent only during increased demand. Exercise ABI involves measuring ABI before and immediately after treadmill walking. A decrease in ABI >20% or ankle pressure >30 mmHg with exercise indicates PAD.

Segmental Pressure Measurements:

Blood pressure measurements at multiple leg levels (upper thigh, lower thigh, calf, ankle) localize disease. A pressure drop >20 mmHg between adjacent segments indicates stenosis in the intervening arterial segment.

Toe-Brachial Index (TBI):

When ankle vessels are non-compressible (ABI >1.40), toe pressures provide alternative assessment. Toe vessels rarely calcify. TBI <0.70 indicates PAD. TBI is particularly valuable in diabetic patients with calcified vessels.

Duplex Ultrasound:

Uses sound waves to visualize arteries and measure blood flow velocity. Increased velocity indicates stenosis. Duplex ultrasound maps PAD extent and severity, identifies specific lesions for intervention planning, and monitors previously treated arteries. It’s non-invasive, involves no radiation or contrast, and can be performed in the office.

Limitations: Operator-dependent, time-consuming for complete lower extremity examination, limited by obesity or extensive arterial calcification, cannot visualize vessels below the knee as reliably as larger vessels.

CT Angiography (CTA):

Provides detailed three-dimensional arterial images from aorta through pedal vessels after intravenous contrast injection. CTA is excellent for intervention planning, accurately defining stenosis location, severity, and length. Acquisition takes minutes, and images can be manipulated to show arteries from multiple angles.

Limitations: Radiation exposure, iodinated contrast (contraindicated in severe kidney disease or contrast allergy), vessels may be obscured by heavy calcification.

MR Angiography (MRA):

Alternative to CTA, MRA provides detailed arterial images without radiation or iodinated contrast (though gadolinium is often used). MRA has similar diagnostic accuracy to CTA. Gadolinium is safer than iodinated contrast for patients with kidney disease (though not entirely risk-free).

Limitations: Longer acquisition time (30-45 minutes), claustrophobia, cannot be performed with certain implanted devices (pacemakers, some metallic implants), tends to overestimate stenosis severity.

Conventional Angiography:

Catheter-based imaging remains the gold standard, providing highest resolution images. Conventional angiography is typically performed when revascularization (angioplasty, stenting, bypass surgery) is planned, allowing diagnosis and treatment in the same session.

Performed by inserting catheter through groin artery (or sometimes arm artery), navigating to diseased vessels, injecting contrast, and taking X-ray images. Therapeutic interventions (balloon angioplasty, stent placement, atherectomy) can be performed immediately after diagnostic imaging.

Risks include bleeding, arterial injury, cholesterol embolization, contrast-induced kidney injury, and rare stroke or heart attack, making it inappropriate for routine diagnosis when non-invasive alternatives are available.

Physical Examination:

While not an imaging test, examination provides valuable diagnostic information. Findings suggesting PAD:

• Absent or weak pulses (femoral, popliteal, dorsalis pedis, posterior tibial)
• Arterial bruits (whooshing sounds over narrowed arteries)
• Cool skin temperature in affected limb
• Pallor with leg elevation, rubor (redness) with dependent position
• Poor hair growth on legs
• Shiny, atrophic skin
• Thickened, slow-growing toenails
• Muscle atrophy
• Non-healing ulcers or wounds on feet or toes

Diagnosing Carotid Artery Disease

Carotid Duplex Ultrasound:

The first-line screening test for carotid stenosis. Combines B-mode ultrasound (visualizes artery structure) with Doppler ultrasound (measures blood flow velocity). Increased velocity indicates stenosis. Carotid ultrasound is performed routinely after stroke or TIA to identify carotid stenosis as the cause.

Stenosis severity classification:

• <50%: Mild stenosis
• 50-69%: Moderate stenosis
• 70-99%: Severe stenosis
• 100%: Complete occlusion

Treatment decisions (carotid endarterectomy or stenting) depend on stenosis severity, with intervention typically recommended for severe stenosis (≥70%) in symptomatic patients or very severe stenosis (≥80-90%) in carefully selected asymptomatic patients.

Advantages: Non-invasive, no radiation, no contrast, relatively inexpensive, can be repeated for monitoring Limitations: Operator-dependent, limited by anatomy (high carotid bifurcation, heavy calcification), cannot visualize intracranial internal carotid artery

CT Angiography (CTA):

Provides detailed three-dimensional carotid artery images. CTA is often performed in acute stroke evaluation, simultaneously assessing for intracranial large vessel occlusion and carotid stenosis. CTA more reliably measures stenosis severity than ultrasound when heavy calcification is present.

CTA is typically used:

• As part of acute stroke protocol
• To confirm severe stenosis detected by ultrasound before intervention
• When ultrasound is technically inadequate

MR Angiography (MRA):

Alternative to CTA without radiation or iodinated contrast. MRA reliably detects significant carotid stenosis but tends to overestimate severity, potentially classifying moderate stenosis as severe. Contrast-enhanced MRA (using gadolinium) is more accurate than non-contrast techniques.

Conventional Angiography:

Gold standard for carotid imaging but typically reserved for immediate pre-operative evaluation when non-invasive tests show discordant results or when carotid stenting is planned (allowing diagnostic imaging and stenting in one procedure).

Advanced Cardiovascular Disease Screening and Risk Assessment

Coronary Artery Calcium (CAC) Score:

Non-contrast CT scan quantifying calcium in coronary arteries. Calcium indicates atherosclerotic plaque. CAC score strongly predicts future cardiovascular events:

• 0: Very low risk
• 1-99: Mild disease
• 100-399: Moderate disease
• ≥400: Extensive disease

CAC scoring helps guide preventive therapy decisions (statin use, aspirin) in people at intermediate cardiovascular risk where treatment benefits are uncertain. However, CAC doesn’t visualize arterial lumen or detect non-calcified plaque, limiting its value in younger patients with early atherosclerosis.

Carotid Intima-Media Thickness (IMT):

Ultrasound measurement of carotid artery wall thickness. Increased IMT indicates subclinical atherosclerosis and predicts cardiovascular events. However, IMT’s predictive value beyond traditional risk factors is modest, limiting clinical use. IMT is primarily a research tool rather than routine clinical test.

Stress Testing:

Exercise or pharmacologic stress testing evaluates for coronary artery disease by detecting inadequate blood flow to heart muscle during increased demand. While primarily a cardiac test, abnormal stress test indicates advanced atherosclerosis and elevated risk for all cardiovascular events including stroke and PAD. Stress testing is covered in detail in our Heart Disease guide.

Blood Tests for Cardiovascular Risk Assessment

While imaging tests diagnose established vascular disease, blood tests identify risk factors driving disease development. Blood testing doesn’t visualize atherosclerosis but reveals the metabolic abnormalities causing it—high cholesterol, diabetes, inflammation, kidney disease. This distinction is crucial: imaging shows disease already present, while blood tests identify who will develop disease.

Lipid Panel:

LDL cholesterol, HDL cholesterol, triglycerides, and total cholesterol. Elevated LDL is the primary driver of atherosclerosis. Advanced lipid testing (apolipoprotein B, LDL particle number and size, lipoprotein(a)) provides additional risk information, particularly when triglycerides are elevated or LDL is borderline.

Glucose and HbA1c:

Screen for prediabetes and diabetes. Even prediabetes increases cardiovascular risk. HbA1c reflects average glucose over 2-3 months, identifying diabetes even when fasting glucose is normal.

Kidney Function:

Creatinine, estimated glomerular filtration rate (eGFR), and urine albumin-to-creatinine ratio. Chronic kidney disease dramatically accelerates cardiovascular disease and increases stroke risk. Even mild kidney dysfunction elevates cardiovascular risk.

High-Sensitivity C-Reactive Protein (hsCRP):

Measures inflammation, which drives atherosclerosis. Elevated hsCRP (>2 mg/L) independently predicts cardiovascular events even with normal cholesterol. hsCRP helps identify high-risk individuals who might benefit from statin therapy despite borderline cholesterol levels.

Blood Pressure:

The single most important measurement for stroke risk assessment. Office blood pressure measurements are standard, but home blood pressure monitoring provides more accurate assessment of usual blood pressure, identifies white coat hypertension (elevated only in medical settings) and masked hypertension (normal in office but elevated at home).

Additional Tests for High-Risk Individuals:

• Lipoprotein(a): Genetic lipid disorder increasing cardiovascular risk that doesn’t respond to statins
• Homocysteine: Elevated levels associated with increased vascular risk
• Apolipoprotein B (ApoB): Better predictor of cardiovascular risk than LDL when triglycerides are elevated
• Hemoglobin A1c: Glycemic control assessment in diabetes

Blood tests should be performed at baseline for all adults, repeated based on cardiovascular risk level (annually for high risk, every 3-5 years for low risk), and monitored more frequently when initiating or adjusting preventive therapies.

The Complementary Role of Blood Testing:

Blood tests don’t replace imaging for diagnosing vascular disease but serve the complementary purpose of identifying modifiable risk factors years before disease develops. Someone with elevated LDL cholesterol, borderline high blood pressure, and prediabetes has no symptoms and normal carotid ultrasound but is developing atherosclerosis that will cause stroke or heart attack in 10-20 years without intervention. Blood testing identifies these individuals when prevention is most effective – before symptoms or imaging abnormalities appear.

---

Why Early Detection and Regular Monitoring Matter

Cardiovascular disease develops silently over decades. The carotid arteries can be 70% blocked before causing symptoms. Peripheral arteries can be severely diseased in people attributing leg symptoms to aging. The combination of imaging (visualizing established disease) and blood testing (identifying risk factors before disease develops) enables comprehensive cardiovascular risk assessment and targeted intervention at whatever disease stage someone presents.

Regular cardiovascular risk assessment combining imaging and laboratory testing allows tracking disease progression and treatment response over time. Annual assessment for moderate to high-risk individuals, more frequent monitoring for very high-risk patients or those with established disease.

---

Prevention Strategies

Approximately 80% of cardiovascular disease is preventable through risk factor management and lifestyle interventions. Prevention is far more effective and less costly than treating cardiovascular events after they occur.

Lifestyle Interventions

Mediterranean Diet:

The most evidence-supported dietary pattern for cardiovascular protection. Emphasizes vegetables, fruits, whole grains, legumes, fish, olive oil, nuts while limiting red meat, processed meats, and sweets. Reduces cardiovascular events by 30%.

Regular Physical Activity:

Target 150 minutes moderate-intensity (brisk walking, cycling) or 75 minutes vigorous-intensity (running, swimming) exercise weekly, plus resistance training twice weekly. Exercise reduces cardiovascular events by 30-40%.

Weight Management:

If overweight or obese, weight loss of 5-10% significantly improves blood pressure, cholesterol, glucose metabolism, and inflammation.

Smoking Cessation:

All smoking cessation interventions (counseling, nicotine replacement, prescription medications) should be offered. Reduces cardiovascular risk by 50% within 1-2 years.

Moderate Alcohol:

If drinking, limit to 1 drink daily for women, 2 for men. Excessive alcohol increases stroke risk.

Sleep Quality:

Target 7-9 hours nightly. Both insufficient and excessive sleep increase cardiovascular risk.

Stress Management:

Chronic stress increases cardiovascular risk through multiple mechanisms. Stress reduction techniques (exercise, meditation, social connection) provide cardiovascular benefits.

Medical Interventions

Blood Pressure Control:

Antihypertensive medications when lifestyle interventions insufficient. Multiple drug classes available, often requiring combination therapy. Target <130/80 mmHg.

Lipid Management:

Statins are first-line therapy for elevated cardiovascular risk. Additional agents (ezetimibe, PCSK9 inhibitors, bempedoic acid) when statins insufficient or not tolerated. Target LDL <100 mg/dL (moderate risk), <70 mg/dL (high risk), <55 mg/dL (very high risk).

Antiplatelet Therapy:

Aspirin or clopidogrel for people at elevated cardiovascular risk without bleeding contraindications.

Diabetes Management:

Glycemic control plus aggressive management of blood pressure, cholesterol, and other cardiovascular risk factors.

Anticoagulation:

For people with atrial fibrillation to prevent cardioembolic stroke.

---

Living With Cardiovascular Disease

Cardiovascular disease diagnosis requires comprehensive lifestyle modifications, medications, regular monitoring, and often psychological adjustment.

Secondary Prevention

After a stroke, TIA, or PAD diagnosis, prevention strategies become more aggressive:

• More intensive blood pressure and cholesterol targets
• Combination antiplatelet therapy in some cases
• Comprehensive risk factor modification
• Cardiac rhythm monitoring for atrial fibrillation
• Regular follow-up with specialists

Rehabilitation and Recovery

Stroke survivors often require comprehensive rehabilitation. PAD patients benefit from supervised exercise programs. Both conditions require long-term management and support.

Monitoring and Follow-up

Regular assessment of blood pressure, cholesterol, glucose, kidney function, and other risk factors guides ongoing treatment adjustments. Annual review with healthcare providers ensures optimal management.

Psychological Impact

Cardiovascular disease and particularly stroke can cause significant psychological distress, depression, and anxiety. Mental health support is an important component of comprehensive care.

---

Comprehensive blood testing — including blood pressure measurement, lipid panel, fasting glucose, kidney function tests, and inflammatory markers — reveals cardiovascular risk years before symptoms develop, enabling targeted prevention strategies that can prevent 80% of cardiovascular disease.